Cardiff Oncology, Inc. (NASDAQ:CRDF)

About the company

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

Sector

Health Services

Industry

Medical and Nursing Services

Employees

14

$0.00M

Total Revenue

14

Employees

$33.46M

Market Capitalization

-2.18

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
DaVita, Inc. DVA 11795.04 11487.00 5.12 13.08 7.85
Chemed Corp. CHE 8094.38 1992.00 11.06 34.03 11.60
Guardant Health, Inc. GH 8079.84 245.00 10.94 -104.67 -31.53
Amedisys, Inc. AMED 6628.38 1980.00 9.57 52.17 6.43
LHC Group, Inc. LHCG 5552.72 2091.00 3.96 56.50 4.73
1Life Healthcare, Inc. ONEM 4852.26 292.00 10.44 -61.13 -27.31
NeoGenomics, Inc. NEO 3827.66 419.00 7.85 902.75 0.82
Natera, Inc. NTRA 3441.22 330.00 14.33 -27.73 -38.27
Invitae Corp. NVTA 3189.12 241.00 12.73 -10.45 -125.90
SmileDirectClub, Inc. SDC 3172.40 769.00 10.05 -25.75 -16.02
The Ensign Group, Inc. ENSG 2256.24 2155.00 3.20 18.23 5.76
Acadia Healthcare Co., Inc. ACHC 2216.72 3130.00 0.91 19.68 3.61
MEDNAX, Inc. MD 1454.99 3508.00 1.01 -1.14 -36.30
Addus HomeCare Corp. ADUS 1259.86 598.00 2.98 61.22 3.33
U.S. Physical Therapy, Inc. USPH 1005.42 478.00 4.12 34.22 6.03
RadNet, Inc. RDNT 770.00 1164.00 6.29 385.00 0.18
Castle Biosciences, Inc. CSTL 730.57 61.00 9.47 716.25 9.75
The Pennant Group, Inc. PNTG 610.68 352.00 7.99 145.40 1.19
Hanger, Inc. HNGR 587.48 1095.00 -36.81 31.55 1.71
Option Care Health, Inc. OPCH 585.36 2539.00 2.47 -5.98 -3.63
Tivity Health, Inc. TVTY 540.00 1255.00 70.31 -1.09 -38.98
Catasys, Inc. CATS 465.29 41.00 -17.00 -14.96 -74.67
Fulgent Genetics, Inc. FLGT 383.77 35.00 5.12 -1918.84 -1.31
American Renal Associates Holdings, Inc. ARA 212.16 824.00 -2.63 -11.84 -2.19
OptiNose, Inc. OPTN 186.62 37.00 5.64 -1.70 -295.66
Aptinyx, Inc. APTX 171.72 4.00 1.78 -3.08 -810.48
CRH Medical Corp. CRHM 163.15 117.00 2.15 111.75 1.52
Exagen, Inc. XGN 149.50 41.00 2.88 -4.67 -76.21
Pro-Dex, Inc. PDEX 68.80 31.00 3.82 15.64 14.50
Guardion Health Sciences, Inc. GHSI 37.06 1.00 2.72 -1.61 -824.43
Cardiff Oncology, Inc. CRDF 33.46 0.00 15.42 -2.18 -883.77
Biocept, Inc. BIOC 29.07 6.00 4.50 -1.06 -463.58
OncoSec Medical, Inc. ONCS 25.61 None 2.10 -0.68 None
Capital Senior Living Corp. CSU 19.20 439.00 -0.61 -0.28 -16.00
American Shared Hospital Services AMS 11.40 20.00 0.42 47.50 1.28
IMAC Holdings, Inc. IMAC 10.89 16.00 1.25 -1.61 -42.30
TrovaGene, Inc. TROV 8.04 0.00 2.03 -0.48 -883.77

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Cardiff Oncology Files Preliminary Prospectus To Resale Of Up To 6.2 Mln Shares Of Common Stock By Selling Stockholders - SEC Filing

10d ago, source: Reuters

June 26 (Reuters) - Cardiff Oncology Inc: * CARDIFF ONCOLOGY INC FILES PRELIMINARY PROSPECTUS RELATED TO RESALE OF UP TO 6.2 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source ...

Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital

23d ago, source: YAHOO!

SAN DIEGO, June 16, 2020 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for ...

Cardiff Oncology Raises $13.5M in Equity Funding

21d ago, source: finsmes.com

Cardiff Oncology, Inc. (Nasdaq: CRDF), a San Diego, CA-based clinical-stage oncology therapeutics company, has entered into a securities purchase agreement, which includes common stock ...

CRDF Cardiff Oncology, Inc. Common Stock

24d ago, source: Nasdaq

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

Cardiff Oncology Announces Expanded Access Program for Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer as Follow-On to Fast Track Designation

1mon ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net SAN DIEGO, June 9, 2020 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology therapeutics ...

BRIEF-Cardiff Oncology Says Data Demonstrate Efficacy, Durability And Safety Of Onvansertib

24d ago, source: Reuters

June 15 (Reuters) - Cardiff Oncology Inc: * CARDIFF ONCOLOGY DATA CONTINUES TO DEMONSTRATE EFFICACY, DURABILITY AND SAFETY OF ONVANSERTIB IN PATIENTS WITH DIFFICULT-TO-TREAT RELAPSED/REFRACTORY ...

BRIEF-Cardiff Oncology Files Preliminary Prospectus To Resale Of Up To 6.2 Mln Shares Of Common Stock By Selling Stockholders - SEC Filing

12d ago, source: Reuters

June 26 (Reuters) - Cardiff Oncology Inc: * CARDIFF ONCOLOGY INC FILES PRELIMINARY PROSPECTUS RELATED TO RESALE OF UP TO 6.2 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.